Literature DB >> 33111990

Socioeconomic Status Mediates Racial Differences Seen Using the AT(N) Framework.

Karin L Meeker1, Julie K Wisch1, Darrell Hudson2, Dean Coble3, Chengjie Xiong3,4, Ganesh M Babulal1, Brian A Gordon5,4, Suzanne E Schindler1,4, Carlos Cruchaga6, Shaney Flores5, Aylin Dincer5, Tammie L Benzinger5,4, John C Morris1,5,4, Beau M Ances1,4.   

Abstract

OBJECTIVES: African Americans are at greater risk for developing Alzheimer's disease (AD) dementia than non-Hispanic whites. In addition to biological considerations (eg, genetic influences and comorbid disorders), social and environmental factors may increase the risk of AD dementia. This paper (1) assesses neuroimaging biomarkers of amyloid (A), tau (T), and neurodegeneration (N) for potential racial differences and (2) considers mediating effects of socioeconomic status (SES) and measures of small vessel and cardiovascular disease on observed race differences.
METHODS: Imaging measures of AT(N) (amyloid and tau positron emission tomography [PET]) structural magnetic resonance imaging (MRI), and resting state functional connectivity (rs-fc) were collected from African American (n = 131) and white (n = 685) cognitively normal participants age 45 years and older. Measures of small vessel and cardiovascular disease (white matter hyperintensities [WMHs] on MRI, blood pressure, and body mass index [BMI]) and area-based SES were included in mediation analyses.
RESULTS: Compared to white participants, African American participants had greater neurodegeneration, as measured by decreased cortical volumes (Cohen's f2 = 0.05, p < 0.001). SES mediated the relationship between race and cortical volumes. There were no significant race effects for amyloid, tau, or rs-fc signature.
INTERPRETATION: Modifiable factors, such as differences in social contexts and resources, particularly area-level SES, may contribute to observed racial differences in AD. Future studies should emphasize collection of relevant psychosocial factors in addition to the development of intentional diversity and inclusion efforts to improve the racial/ethnic and socioeconomic representativeness of AD studies. ANN NEUROL 2021;89:254-265.
© 2020 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33111990      PMCID: PMC7903892          DOI: 10.1002/ana.25948

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   11.274


  43 in total

1.  Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms.

Authors:  Carlos Cruchaga; Jorge L Del-Aguila; Benjamin Saef; Kathleen Black; Maria Victoria Fernandez; John Budde; Laura Ibanez; Yuetiva Deming; Manav Kapoor; Giuseppe Tosto; Richard P Mayeux; David M Holtzman; Anne M Fagan; John C Morris; Randall J Bateman; Alison M Goate; Oscar Harari
Journal:  Alzheimers Dement       Date:  2017-09-21       Impact factor: 21.566

Review 2.  Alzheimer's disease in African Americans: risk factors and challenges for the future.

Authors:  Lisa L Barnes; David A Bennett
Journal:  Health Aff (Millwood)       Date:  2014-04       Impact factor: 6.301

3.  Assessment of Racial Disparities in Biomarkers for Alzheimer Disease.

Authors:  John C Morris; Suzanne E Schindler; Lena M McCue; Krista L Moulder; Tammie L S Benzinger; Carlos Cruchaga; Anne M Fagan; Elizabeth Grant; Brian A Gordon; David M Holtzman; Chengjie Xiong
Journal:  JAMA Neurol       Date:  2019-03-01       Impact factor: 18.302

4.  The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.

Authors:  William E Klunk; Robert A Koeppe; Julie C Price; Tammie L Benzinger; Michael D Devous; William J Jagust; Keith A Johnson; Chester A Mathis; Davneet Minhas; Michael J Pontecorvo; Christopher C Rowe; Daniel M Skovronsky; Mark A Mintun
Journal:  Alzheimers Dement       Date:  2014-10-28       Impact factor: 21.566

5.  Early-life origins of adult disease: national longitudinal population-based study of the United States.

Authors:  Rucker C Johnson; Robert F Schoeni
Journal:  Am J Public Health       Date:  2011-10-20       Impact factor: 9.308

6.  The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics.

Authors:  M X Tang; Y Stern; K Marder; K Bell; B Gurland; R Lantigua; H Andrews; L Feng; B Tycko; R Mayeux
Journal:  JAMA       Date:  1998-03-11       Impact factor: 56.272

7.  Partial volume correction in quantitative amyloid imaging.

Authors:  Yi Su; Tyler M Blazey; Abraham Z Snyder; Marcus E Raichle; Daniel S Marcus; Beau M Ances; Randall J Bateman; Nigel J Cairns; Patricia Aldea; Lisa Cash; Jon J Christensen; Karl Friedrichsen; Russ C Hornbeck; Angela M Farrar; Christopher J Owen; Richard Mayeux; Adam M Brickman; William Klunk; Julie C Price; Paul M Thompson; Bernadino Ghetti; Andrew J Saykin; Reisa A Sperling; Keith A Johnson; Peter R Schofield; Virginia Buckles; John C Morris; Tammie L S Benzinger
Journal:  Neuroimage       Date:  2014-12-05       Impact factor: 6.556

8.  Extracting and summarizing white matter hyperintensities using supervised segmentation methods in Alzheimer's disease risk and aging studies.

Authors:  Vamsi Ithapu; Vikas Singh; Christopher Lindner; Benjamin P Austin; Chris Hinrichs; Cynthia M Carlsson; Barbara B Bendlin; Sterling C Johnson
Journal:  Hum Brain Mapp       Date:  2014-02-07       Impact factor: 5.038

9.  Association of Neighborhood-Level Disadvantage With Cerebral and Hippocampal Volume.

Authors:  Jack F V Hunt; William Buckingham; Alice J Kim; Jennifer Oh; Nicholas M Vogt; Erin M Jonaitis; Tenah K Hunt; Megan Zuelsdorff; Ryan Powell; Derek Norton; Robert A Rissman; Sanjay Asthana; Ozioma C Okonkwo; Sterling C Johnson; Amy J H Kind; Barbara B Bendlin
Journal:  JAMA Neurol       Date:  2020-04-01       Impact factor: 18.302

10.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.

Authors:  J C Lambert; C A Ibrahim-Verbaas; D Harold; A C Naj; R Sims; C Bellenguez; A L DeStafano; J C Bis; G W Beecham; B Grenier-Boley; G Russo; T A Thorton-Wells; N Jones; A V Smith; V Chouraki; C Thomas; M A Ikram; D Zelenika; B N Vardarajan; Y Kamatani; C F Lin; A Gerrish; H Schmidt; B Kunkle; M L Dunstan; A Ruiz; M T Bihoreau; S H Choi; C Reitz; F Pasquier; C Cruchaga; D Craig; N Amin; C Berr; O L Lopez; P L De Jager; V Deramecourt; J A Johnston; D Evans; S Lovestone; L Letenneur; F J Morón; D C Rubinsztein; G Eiriksdottir; K Sleegers; A M Goate; N Fiévet; M W Huentelman; M Gill; K Brown; M I Kamboh; L Keller; P Barberger-Gateau; B McGuiness; E B Larson; R Green; A J Myers; C Dufouil; S Todd; D Wallon; S Love; E Rogaeva; J Gallacher; P St George-Hyslop; J Clarimon; A Lleo; A Bayer; D W Tsuang; L Yu; M Tsolaki; P Bossù; G Spalletta; P Proitsi; J Collinge; S Sorbi; F Sanchez-Garcia; N C Fox; J Hardy; M C Deniz Naranjo; P Bosco; R Clarke; C Brayne; D Galimberti; M Mancuso; F Matthews; S Moebus; P Mecocci; M Del Zompo; W Maier; H Hampel; A Pilotto; M Bullido; F Panza; P Caffarra; B Nacmias; J R Gilbert; M Mayhaus; L Lannefelt; H Hakonarson; S Pichler; M M Carrasquillo; M Ingelsson; D Beekly; V Alvarez; F Zou; O Valladares; S G Younkin; E Coto; K L Hamilton-Nelson; W Gu; C Razquin; P Pastor; I Mateo; M J Owen; K M Faber; P V Jonsson; O Combarros; M C O'Donovan; L B Cantwell; H Soininen; D Blacker; S Mead; T H Mosley; D A Bennett; T B Harris; L Fratiglioni; C Holmes; R F de Bruijn; P Passmore; T J Montine; K Bettens; J I Rotter; A Brice; K Morgan; T M Foroud; W A Kukull; D Hannequin; J F Powell; M A Nalls; K Ritchie; K L Lunetta; J S Kauwe; E Boerwinkle; M Riemenschneider; M Boada; M Hiltuenen; E R Martin; R Schmidt; D Rujescu; L S Wang; J F Dartigues; R Mayeux; C Tzourio; A Hofman; M M Nöthen; C Graff; B M Psaty; L Jones; J L Haines; P A Holmans; M Lathrop; M A Pericak-Vance; L J Launer; L A Farrer; C M van Duijn; C Van Broeckhoven; V Moskvina; S Seshadri; J Williams; G D Schellenberg; P Amouyel
Journal:  Nat Genet       Date:  2013-10-27       Impact factor: 38.330

View more
  11 in total

1.  Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: A Secondary Analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Cohort Study.

Authors:  Consuelo H Wilkins; Charles C Windon; Peggye Dilworth-Anderson; Justin Romanoff; Constantine Gatsonis; Lucy Hanna; Charles Apgar; Ilana F Gareen; Carl V Hill; Bruce E Hillner; Andrew March; Barry A Siegel; Rachel A Whitmer; Maria C Carrillo; Gil D Rabinovici
Journal:  JAMA Neurol       Date:  2022-10-03       Impact factor: 29.907

2.  Diversifying Recruitment Registries: Considering Neighborhood Health Metrics.

Authors:  J D Grill; A Kind; D Hoang; D L Gillen
Journal:  J Prev Alzheimers Dis       Date:  2022

3.  Using Fractional Anisotropy Imaging to Detect Mild Cognitive Impairment and Alzheimer's Disease among Mexican Americans and Non-Hispanic Whites: A HABLE Study.

Authors:  James R Hall; Leigh A Johnson; Fan Zhang; Melissa Petersen; Arthur W Toga; Yonggang Shi; David Mason; Robert A Rissman; Kristine Yaffe; Sid E O'Bryant
Journal:  Dement Geriatr Cogn Disord       Date:  2021-09-17       Impact factor: 3.346

4.  Functional connectivity changes in cerebral small vessel disease - a systematic review of the resting-state MRI literature.

Authors:  Maximilian Schulz; Caroline Malherbe; Bastian Cheng; Götz Thomalla; Eckhard Schlemm
Journal:  BMC Med       Date:  2021-05-05       Impact factor: 8.775

Review 5.  The Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat): Driving Multicentric Research and Implementation Science.

Authors:  Agustin Ibanez; Jennifer S Yokoyama; Katherine L Possin; Diana Matallana; Francisco Lopera; Ricardo Nitrini; Leonel T Takada; Nilton Custodio; Ana Luisa Sosa Ortiz; José Alberto Avila-Funes; Maria Isabel Behrens; Andrea Slachevsky; Richard M Myers; J Nicholas Cochran; Luis Ignacio Brusco; Martin A Bruno; Sonia M D Brucki; Stefanie Danielle Pina-Escudero; Maira Okada de Oliveira; Patricio Donnelly Kehoe; Adolfo M Garcia; Juan Felipe Cardona; Hernando Santamaria-Garcia; Sebastian Moguilner; Claudia Duran-Aniotz; Enzo Tagliazucchi; Marcelo Maito; Erika Mariana Longoria Ibarrola; Maritza Pintado-Caipa; Maria Eugenia Godoy; Vera Bakman; Shireen Javandel; Kenneth S Kosik; Victor Valcour; Bruce L Miller
Journal:  Front Neurol       Date:  2021-03-11       Impact factor: 4.003

6.  Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project.

Authors:  Michael L Alosco; Megan L Mariani; Charles H Adler; Laura J Balcer; Charles Bernick; Rhoda Au; Sarah J Banks; William B Barr; Sylvain Bouix; Robert C Cantu; Michael J Coleman; David W Dodick; Lindsay A Farrer; Yonas E Geda; Douglas I Katz; Inga K Koerte; Neil W Kowall; Alexander P Lin; Daniel S Marcus; Kenneth L Marek; Michael D McClean; Ann C McKee; Jesse Mez; Joseph N Palmisano; Elaine R Peskind; Yorghos Tripodis; Robert W Turner; Jennifer V Wethe; Jeffrey L Cummings; Eric M Reiman; Martha E Shenton; Robert A Stern
Journal:  Alzheimers Res Ther       Date:  2021-08-12       Impact factor: 8.823

7.  Neurodegeneration from the AT(N) framework is different among Mexican Americans compared to non-Hispanic Whites: A Health & Aging Brain among Latino Elders (HABLE) Study.

Authors:  Sid E O'Bryant; Fan Zhang; Melissa Petersen; James Hall; Leigh A Johnson; Kristine Yaffe; Meredith Braskie; Robert A Rissman; Rocky Vig; Arthur W Toga
Journal:  Alzheimers Dement (Amst)       Date:  2022-02-09

Review 8.  Culture, Ethnicity, and Level of Education in Alzheimer's Disease.

Authors:  Mónica Rosselli; Idaly Vélez Uribe; Emily Ahne; Layaly Shihadeh
Journal:  Neurotherapeutics       Date:  2022-03-28       Impact factor: 7.620

9.  Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light.

Authors:  Suzanne E Schindler; Thomas K Karikari; Nicholas J Ashton; Rachel L Henson; Kevin E Yarasheski; Tim West; Mathew R Meyer; Kristopher M Kirmess; Yan Li; Benjamin Saef; Krista L Moulder; David Bradford; Anne M Fagan; Brian A Gordon; Tammie L S Benzinger; Joyce Balls-Berry; Randall J Bateman; Chengjie Xiong; Henrik Zetterberg; Kaj Blennow; John C Morris
Journal:  Neurology       Date:  2022-04-21       Impact factor: 11.800

Review 10.  Alzheimer disease in African American individuals: increased incidence or not enough data?

Authors:  Lisa L Barnes
Journal:  Nat Rev Neurol       Date:  2021-12-06       Impact factor: 44.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.